Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

3,4-Dicaffeoylquinic acid (3,4-DCQA) is a polyphenol with diverse biological activities.1,2,3,4 3,4-DCQA (1-500 μg/ml) inhibits acetylcholinesterase (ACE) and α-glucosidase in a concentration-dependent manner.1,3 It reduces mutagenicity of Trp-P-1 against S. typhimurium by 59% when used at a concentration of 0.57 mM.2 3,4-DCQA has antioxidant activity in ferric reducing, β-carotene bleaching, and DPPH scavenging assays (EC50s = 2.18, 23.85, and 68.91 μg/ml, respectively).3 It is cytotoxic to NCI-H23 lung adenocarcinoma cells (EC50 = 3.26 μg/ml). In vivo, 3,4-DCQA (50 mg/kg) increases tumor necrosis factor-related apoptosis inducing ligand (TRAIL) mRNA, reduces influenza H1N1 hemagglutinin (HA) mRNA, and increases survival in a mouse model of influenza A infection.4
WARNING This product is not for human or veterinary use.
1. Angiotensin converting enzyme inhibitors from Cuscuta japonica Choisy. J. Ethnopharmacol. 83(1-2), 105-108 (2012).
2. Antimutagenicity of mono-
3. Cytotoxic, apoptotic and anti-
4. 3,4-